Reduced adiponectin levels have been associated with metabolic syndrome [4,48]; nevertheless, studies in vitro and in the animal model have revealed an antiproliferative activity for adiponectin [49,50], suggesting that increased adiponectin levels might have a protective role in HCC. The gene discussed is ADIPOQ; the disease is hepatocellular carcinoma.